Breast cancer and endometriosis drug Zoladex is being pulled from Australia. How will women be affected?
Illustration
AI Summary
The vital medicine, made by AstraZeneca, will not be available from November, possibly leaving thousands of women without treatment Get our breaking news email, free app or daily news podcast Thousands of women could be left without vital breast cancer and endometriosis medicine when AstraZeneca removes its treatment from the Pharmaceutical Benefits Scheme (PBS) and the private market, experts warn. Newsiline summarises this report from The Guardian Australia and links readers to the original publisher for the full story.
Key Points
- Original report published by The Guardian Australia.
- Newsiline stores only headline metadata, source credit, and a short summary.
- Readers are directed to the publisher for the complete article.
Why It Matters
This story may affect readers following the category, country, or source involved. Newsiline keeps the summary neutral and points to the publisher for full context.
Sources
The Guardian Australia: Read full story at source
Newsiline provides short summaries and links to publishers. It does not republish full articles.